In Vitro Susceptibility of Aztreonam-Vaborbactam, Aztreonam-Relebactam and Aztreonam-Avibactam Associations against Metallo-β-Lactamase-Producing Gram-Negative Bacteria

Background: Despite the availability of new options (ceftazidime-avibactam, imipenem-relebactam, meropenem-vaborbactam and cefiderocol), it is still very difficult to treat infections caused by metallo-β-lactamase (MBLs)-producers resistant to aztreonam. The in vitro efficacy of aztreonam in associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Emeraud, Cécile, Bernabeu, Sandrine, Dortet, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604182/
https://www.ncbi.nlm.nih.gov/pubmed/37887194
http://dx.doi.org/10.3390/antibiotics12101493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604182/
https://www.ncbi.nlm.nih.gov/pubmed/37887194
http://dx.doi.org/10.3390/antibiotics12101493

Ejemplares similares